Hello irrextApent! As you ask...part of article: ATLANTA--(BUSINESS WIRE)--Sep 10, 2008 - Sciele Pharma, Inc. (NASDAQ:SCRX) and Addrenex Pharmaceuticals today announced that the preliminary analysis of the Phase III clinical study investigating the use of Clonicel(R) for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) showed statistically significant improvement over placebo.
